Anticancer agent 183

• Description :

  Anticancer agent 183 (compound 4h) inhibits the matrix metalloproteinase-9 (MMP-9) viability than 75% at 100 μg/mL. Anticancer agent 183 has anticancer activity with an IC50 value of apoptotic[1].

• CAS Number :

  [3018960-58-9]

• UNSPSC :

  12352005

• Target :

  Apoptosis; MMP

• Type :

  Reference compound

• Related Pathways :

  Apoptosis; Metabolic Enzyme/Protease

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/anticancer-agent-183.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NC1=CC=CC=C1)CSC2=NN=C(COC3=CC=CC=C3NC(C)=O)O2

• Molecular Formula :

  C19H18N4O4S

• Molecular Weight :

  398.44

• References & Citations :

  [1]Leyla Yurtta, et al. Synthesis of Some New 1,3,4-Oxadiazole Derivatives and Evaluation of Their Anticancer Activity. ACS Omega. 2023, 8, 51.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  MMP-9